PULMONARY ARTERY DILATATION

This adverse event was reported 344 times

These drugs are most commonly taken by patients reporting PULMONARY ARTERY DILATATION:

# Drug Count
0 FUROSEMIDE 35
1 MACITENTAN 33
2 SILDENAFIL CITRATE 31
3 ALBUTEROL SULFATE 28
4 ASPIRIN 26
5 ASPIRIN 325 MG 25
6 ASPIRIN 81 MG 25
7 PREDNISONE 25
8 SILDENAFIL 24
9 TADALAFIL 24
See all common drugs associated with PULMONARY ARTERY DILATATION

PULMONARY ARTERY DILATATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 URIC ACID 1 0.0435
1 SODIUM PHOSPHATE, DIBASIC AND SODIUM PHOSPHATE, MONOBASIC 1 0.0122
2 ILOPROST 4 0.0043
3 MILRINONE LACTATE 1 0.0036
4 FLUDEOXYGLUCOSE F-18 1 0.0035
5 SODIUM NITROPRUSSIDE 1 0.0026
6 TETRACAINE 1 0.0025
7 RILONACEPT 2 0.0017
8 SORBITOL 1 0.0017
9 FENFLURAMINE 8 0.0015
See all drugs enriched for association with PULMONARY ARTERY DILATATION

PULMONARY ARTERY DILATATION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Prostacycline [EPC] 4 0.0043
1 Interleukin-5 Antagonist [EPC] 1 0.0015
2 Oxytocic [EPC] 3 0.0010
3 Prostacyclin Receptor Agonist [EPC] 22 0.0008
4 Hematopoietic Stem Cell Mobilizer [EPC] 1 0.0007
5 Provitamin D2 Compound [EPC] 13 0.0004
6 Pyridone [EPC] 16 0.0004
7 CD38-directed Cytolytic Antibody [EPC] 2 0.0003
8 Radioactive Diagnostic Agent [EPC] 1 0.0003
9 Phosphodiesterase 5 Inhibitor [EPC] 42 0.0003
See all drug classes enriched for association with PULMONARY ARTERY DILATATION